Rural 340B Access Act of 2025
Sponsor

Full profile: /officials/B001301
Source: Congress.gov · FEC
Cosponsors (6)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Committee Activity
Currently in
- House Committee on Energy and CommerceReferred To · 2025-01-03
Previously
- Energy and Commerce CommitteeReferred To · 2025-01-03
Plain-English Summary
Rural 340B Access Act of 2025 This bill makes rural emergency hospitals (REHs) eligible to purchase drugs from manufacturers at discounted prices by participating in the Health Resources and Services Administration’s (HRSA’s) 340B drug pricing program. HRSA’s 340B program requires drug manufacturers that participate in the Medicaid program to sell certain outpatient drugs at discounted prices to entities listed as eligible under current law. Additionally, in 2020, Congress established REHs as a new Medicare provider designation for hospitals in rural areas providing emergency department services, observation care, and other outpatient medical and health services for which the annual per patient average length of stay does not exceed 24 hours. The bill adds qualifying REHs to the list of entities that are eligible to participate in the 340B program.
Plain-English rewrite of the Congressional Research Service summary published on Congress.gov. Cached and reviewed.
Subjects
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- HR6835Veterans STAND ActReferred to Committee · 2026-06-30
- HR6549VA Contracting and Procurement ActReferred to Committee · 2026-05-20
- HR6993BEACON Act of 2026Referred to Committee · 2026-05-14
- HR7683VA Fiscal Management Modernization ActReferred to Committee · 2026-05-14